Milestone issue by Greenfern

Apr 22, 2022 | Latest News

22.4.22 Greenfern Industries has issued 877,659 ordinary shares under under GFI’s agreement with Cannvalate to satisfy in advance a first milestone of 1000 new patients. GFI’s agreement with Cannvalate is priced NZ$0.17090925 per Ordinary Share. (Calculated by reference to the 90-day volume weighted average price (VWAP) of the GFI's shares traded on the There is […]

 


 

You need an active membership to keep reading

either log in via the form below or click here to subscribe

If you have recently subscribed and selected to pay by bank transfer our admin team will activate your membership once payment has cleared

[adrotate banner="4"]

Your Advertisement Here

Contact us now to discuss advertising options

Your Advertisement Here

Contact us now to discuss advertising options